What happened with GNW today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Genworth Financial’s largest revenue source is its legacy insurance business, called Closed Block. These subsidiaries service previously sold long-term care and life insurance policies and annuities rather than actively seek new sales. Policyholders pay premiums and fees, and the insurers invest accumulated funds to help pay future benefits. Premiums and investment income account for most of Genworth’s revenue.
Genworth also controls publicly traded Enact Holdings. Enact protects U.S. lenders and mortgage investors against part of the losses when borrowers with low-down-payment mortgages fail to pay. Mortgage originators usually select the insurer; borrowers typically pay the premiums, although lenders may pay them. Revenue depends on new mortgage lending and how long existing coverage stays in force. One lender customer supplies a meaningful share of Enact’s business. Enact must meet Fannie Mae and Freddie Mac’s insurer eligibility and capital requirements, and cannot raise premiums on coverage already issued.
The holding company depends heavily on dividends and other capital returns from Enact, which insurance rules and capital requirements can restrict. It does not expect capital returns from the legacy insurers. Those insurers’ ability to fund long-term care claims depends heavily on obtaining regulatory approval for premium increases and associated benefit reductions. They also have a substantial reinsurance exposure to UFLIC, an affiliate of GE Aerospace; reinsurance does not remove their obligations to policyholders.
Genworth is building newer aging-care businesses under CareScout. CareScout Services charges for care assessments, planning and connections to providers. CareScout Insurance now sells Care Assurance individual long-term care insurance, separate from the legacy business.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
Genworth’s results hinge on Enact’s mortgage-insurance earnings and legacy long-term-care claims, with AXA’s litigation against Santander also offering a possible substantial one-time recovery.
Majority-owned Enact Holdings, Inc. feeds its mortgage-insurance earnings into Genworth’s consolidated results and returns capital that supports CareScout, buybacks and debt reduction. It protects lenders against losses on low-down-payment U.S. home loans; its $407 million of capital returns to Genworth Holdings in 2025 shows the funding role alongside its insurance earnings.
MGIC Investment Corp. competes with Genworth’s Enact for U.S. lenders’ business protecting residential mortgages against borrower default. Watch MGIC’s new mortgage insurance written as a benchmark for the business Enact is competing to win.
Essent Group LTD competes with Genworth’s Enact to protect U.S. lenders against losses on low-down-payment home loans. Its mortgage-insurance business is the comparison to watch, rather than its title insurance and settlement services, because mortgage originators choose which insurer gets their loans.
Radian Group Inc. competes with Genworth’s Enact for premiums on low-down-payment U.S. first-lien home loans, protecting lenders and investors against default losses. Its borrower-specific mortgage-insurance quotes offer a concrete view of the pricing competition Enact faces.
NMI Holdings Inc. and Genworth’s Enact sell insurance covering default losses on low-down-payment first-lien mortgages to overlapping U.S. lender customers. NMI’s new insurance written among mortgage banks, banks and credit unions is a useful comparison for Enact’s business with those customers.
Manulife Financial’s John Hancock manages a substantial U.S. long-term-care insurance block facing the same aging-policyholder and rising claims-cost pressures as Genworth’s legacy policies. Its long-term-care claims news offers a comparison for those pressures at Genworth.
CNO Financial Group, Inc.’s Bankers Life competes with Genworth’s CareScout in selling long-term-care insurance and also manages existing policies facing similar aging-related claims pressures. That makes its long-term-care business relevant to both Genworth’s new sales and its legacy claims burden.
Aegon Ltd.’s Transamerica manages legacy U.S. long-term-care policies exposed to claims inflation and reserve pressures similar to Genworth’s Closed Block. News on that book’s claims costs and reserves offers a comparison for Genworth’s legacy insurance, rather than its new sales.
Arch Capital competes with Genworth’s Enact to sell mortgage insurance to U.S. lenders, but its substantial specialty insurance and reinsurance businesses make group earnings a less direct comparison. Watch its mortgage-insurance business for competition affecting Enact, rather than its worldwide insurance totals.
Genworth relies on Reinsurance Group of America to reimburse part of its legacy insurers’ risks in exchange for premiums—a reinsurance arrangement with $2.629 billion of recoverable exposure to RGA Reinsurance Company at December 31, 2025, measured at the locked-in discount rate. RGA’s ability to pay matters because Genworth still owes policyholders even if its reinsurer fails to perform.
Brighthouse Financial transfers a large legacy long-term-care insurance block’s claims risk to Genworth affiliates, making Genworth responsible for the reinsured claims. Trust accounts secure those obligations, but Brighthouse remains directly liable to policyholders, so claims on this block connect the two insurers rather than Brighthouse’s new annuity and life sales.
Ameriprise Financial’s RiverSource shares specified existing long-term-care policy risks equally with Genworth subsidiaries, so claims on those policies reach both companies; for RiverSource Life of New York, only policies issued in 1996 or later qualify. RiverSource can choose to take back some or all of Genworth’s share, making any such recapture news directly relevant to Genworth’s claims exposure.
Genworth depends on GE Aerospace’s affiliate UFLIC to reimburse legacy insurance risks, with $12.592 billion of recoverable exposure at December 31, 2025, measured at the locked-in discount rate—a significant concentration backed by trust accounts. GE mainly sells and services jet engines, but UFLIC’s ability to meet these insurance obligations is the news that matters for Genworth, which remains liable to policyholders.
Fed Interest Rate Decision
Genworth’s insurance business responds to interest rates because they affect returns on invested premiums and the cost of its long-term-care, life and fixed-annuity promises, while mortgage rates influence Enact’s loan originations, refinancing and mortgage-insurance premiums.
Expected4.0%Last release4.0%
If it comes in above expectations
Higher-than-expected rates can improve returns on new investments, but may also raise costs tied to Genworth’s insurance promises; for Enact, costlier borrowing can curb mortgage originations and new insurance premiums.
If it comes in below expectations
Lower-than-expected rates can reduce returns on new investments and make refinancing more attractive, potentially shrinking Enact’s insured loans and premiums; they can also weaken returns on Genworth’s insurance assets relative to its promises.
Ameriprise Financial, Inc. earningsAMP
Ameriprise's long-term-care disclosures can show whether claims on policies it shares with Genworth are increasing, or whether it is taking back some of Genworth's share of the risk.
Look for Ameriprise's disclosures on long-term-care claims and shared policy risks, and for any mention that it is taking back some of Genworth's share. Rising claims on these policies increase the portion of the burden Genworth shares; a disclosed recapture of some or all of that share would reduce Genworth's exposure to future claims on this block. Silence about recapture does not establish that nothing changed, so read the claims trend and any stated change in risk-sharing together.
CNO Financial Group, Inc. earningsCNO
CNO Financial Group's long-term-care insurance sales show whether a competitor is gaining business in the market where Genworth's CareScout is trying to win new customers.
Look for CNO's disclosures about Bankers Life long-term-care insurance sales or new business; group-wide results do not measure this product line. Growth would show a competitor winning more new policies and add pressure on CareScout to attract customers; slower sales could mean less expansion from this rival, but would not by itself establish whether overall demand has weakened. The takeaway is about competition in long-term-care insurance, not CNO's other businesses.
Genworth Financial, Inc. earningsThis company
Genworth's results show whether Enact's mortgage-insurance earnings can keep supporting the company as its legacy long-term-care policies generate losses.
Compare Enact's adjusted operating income available to Genworth's common stockholders with the adjusted operating loss in the legacy long-term-care business; adjusted operating income is the company's measure of ongoing performance after excluding specified items. Higher Enact income alongside a narrower long-term-care loss would show that the main earnings engine is better absorbing claims from old policies; weaker Enact income and a wider loss would mean a thinner earnings buffer. Also check whether Enact returns capital to its parent: earnings alone do not put cash at Genworth's holding company, so the conclusion depends on both earnings and actual distributions.
Enact Holdings, Inc. earningsACT
Enact Holdings' report shows whether Genworth's majority-owned mortgage insurer is still generating earnings and returning capital to its parent.
Read Enact's adjusted operating income available to Genworth's common stockholders alongside any disclosed dividends or other capital returns. Higher income with continued distributions would show that Enact supports both Genworth's consolidated results and cash at the parent; lower income weakens the first support, while regulatory capital rules or Enact's own needs can limit actual distributions. Only both together show that the subsidiary is contributing earnings as well as cash.
MGIC Investment Corp. earningsMTG
MGIC Investment's new mortgage insurance written shows whether this direct competitor is winning more or fewer loans from U.S. lenders than before.
Compare MGIC's new insurance written—the amount of newly insured loans—with Enact's own new business, rather than comparing group revenues. If MGIC grows while Enact lags, this direct rival is winning more business and the competitive pressure on Enact is greater; if both grow, the market may simply be offering more loans to insure, so MGIC's growth alone does not prove Enact lost share. The comparison helps separate a competitor's gains from a growing market.
Radian Group Inc. earningsRDN
Radian Group's pricing and new mortgage-insurance business show whether this competitor is putting pressure on the prices Enact can charge for loans.
Look for Radian's disclosures on mortgage-insurance quotes, the loans it insures and new business, and compare them with Enact's new business and risk mix. If Radian is pricing comparable loans more aggressively, lenders choosing an insurer have more leverage to press Enact on price, potentially limiting premium income on new policies; less aggressive pricing would mean less direct pressure. Loan risks and terms differ, so a premium figure alone does not show whose pricing is more profitable.
Brighthouse Financial, Inc. earningsBHF
Brighthouse's legacy long-term-care disclosures can show whether claims are adding pressure to the block reinsured by Genworth's affiliates.
Look for Brighthouse's disclosures on claims, policy liabilities and reinsurance for this legacy long-term-care block; its new annuity and life sales do not measure this exposure. Rising claims on the block would increase the claims burden Genworth's affiliates bear as reinsurers; stable claims would show less added pressure from this specific arrangement. Brighthouse remains directly liable to policyholders, so its report helps track claims tied to the reinsurance arrangement, not replace Genworth's own results.
Reinsurance Group of America, Incorporated earningsRGA
Reinsurance Group of America's report can show changes in the capacity of a reinsurer that owes Genworth recoveries, while Genworth remains liable to its policyholders.
Watch RGA's disclosures on capital, financial strength and reinsurance risks, and whether they mention business connected to Genworth. At year-end 2025, Genworth had $2.629 billion of recoverables from RGA Reinsurance Company, measured at the locked-in discount rate. Deteriorating capacity would make that exposure more concerning; stable capacity would support confidence in the counterparty. RGA's overall results do not prove that this specific balance has been paid or is at risk of default, and Genworth remains directly liable to policyholders.
